|
|
||||||||




* Laboratory of Immunology, Medical Clinic I, University of Mainz, Mainz, Germany;
Department of Internal Medicine, University of Rome "Tor Vergata", Rome, Italy; and
Department of Biochemistry, University of Kiel, Kiel, Germany
Chronic inflammatory diseases may develop when regulatory T cells (Tregs) fail to control the balance between tolerance and immunity. Alternatively, activated immune cells might prevent the induction or activation of Tregs in such diseases. In this study, we demonstrate that trans-signaling into T cells via the soluble IL-6 receptor completely abrogates the de novo induction of adaptive Tregs. Mechanistically, IL-6 trans-signaling augmented the expression of the TGF-
signaling inhibitor SMAD7. Consequently, SMAD7 overexpression in T cells using newly created transgenic mice rendered CD4+CD25– T cells resistant to the induction of FoxP3. Finally, IL-6 trans-signaling inhibited Treg-mediated suppression in a murine model of colitis. In summary, IL-6 trans-signaling into T cells emerges as a key pathway for blockade of the development of adaptive Tregs and thus may play a pivotal role in shifting the balance between effector and regulatory T cell numbers in chronic inflammatory and autoimmune diseases.
The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
1 This work was supported by the collaborative research grant SFB548 from the Deutsche Forschungsgemeinschaft (to C.B. and M.F.N.).
2 S.D. and M.C.F. share first authorship.
3 M.F.N. and C.B. share senior authorship.
4 Address correspondence and reprint requests to Dr. Christoph Becker, Laboratory of Immunology, Medical Clinic I, University of Mainz, Obere Zahlbacher Strasse 63, 55131 Mainz, Germany. E-mail address: chbecker{at}uni-mainz.de
5 Abbreviations used in this paper: Treg, regulatory T cell; HA, hemagglutinin; HA-TCRtg/RAG, transgenic for HA-specific TCR (mice); HIL-6, Hyper-IL-6; HPRT, hypoxanthine phosphoribosyltransferase; iTreg, induced Treg; sIL-6R, soluble IL-6R.
This article has been cited by other articles:
![]() |
G. Lal and J. S. Bromberg Epigenetic mechanisms of regulation of Foxp3 expression Blood, October 29, 2009; 114(18): 3727 - 3735. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. S. Turner, L. P. Kane, and P. A. Morel Dominant Role of Antigen Dose in CD4+Foxp3+ Regulatory T Cell Induction and Expansion J. Immunol., October 15, 2009; 183(8): 4895 - 4903. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Wang, T. W. J. Huizinga, and R. E. M. Toes De Novo Generation and Enhanced Suppression of Human CD4+CD25+ Regulatory T Cells by Retinoic Acid J. Immunol., September 15, 2009; 183(6): 4119 - 4126. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Baban, P. R. Chandler, M. D. Sharma, J. Pihkala, P. A. Koni, D. H. Munn, and A. L. Mellor IDO Activates Regulatory T Cells and Blocks Their Conversion into Th17-Like T Cells J. Immunol., August 15, 2009; 183(4): 2475 - 2483. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Brahmachari and K. Pahan Suppression of Regulatory T Cells by IL-12p40 Homodimer via Nitric Oxide J. Immunol., August 1, 2009; 183(3): 2045 - 2058. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Neveu, J. B. Allard, O. Dienz, M. J. Wargo, G. Ciliberto, L. A. Whittaker, and M. Rincon IL-6 Is Required for Airway Mucus Production Induced by Inhaled Fungal Allergens J. Immunol., August 1, 2009; 183(3): 1732 - 1738. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Chen, R. Das, R. Komorowski, A. Beres, M. J. Hessner, M. Mihara, and W. R. Drobyski Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease Blood, July 23, 2009; 114(4): 891 - 900. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Monari, S. Bevilacqua, M. Piccioni, E. Pericolini, S. Perito, M. Calvitti, F. Bistoni, T. R. Kozel, and A. Vecchiarelli A Microbial Polysaccharide Reduces the Severity of Rheumatoid Arthritis by Influencing Th17 Differentiation and Proinflammatory Cytokines Production J. Immunol., July 1, 2009; 183(1): 191 - 200. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Nowell, A. S. Williams, S. A. Carty, J. Scheller, A. J. Hayes, G. W. Jones, P. J. Richards, S. Slinn, M. Ernst, B. J. Jenkins, et al. Therapeutic Targeting of IL-6 Trans Signaling Counteracts STAT3 Control of Experimental Inflammatory Arthritis J. Immunol., January 1, 2009; 182(1): 613 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Duan, T. So, and M. Croft Antagonism of Airway Tolerance by Endotoxin/Lipopolysaccharide through Promoting OX40L and Suppressing Antigen-Specific Foxp3+ T Regulatory Cells J. Immunol., December 15, 2008; 181(12): 8650 - 8659. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Samanta, B. Li, X. Song, K. Bembas, G. Zhang, M. Katsumata, S. J. Saouaf, Q. Wang, W. W. Hancock, Y. Shen, et al. TGF-{beta} and IL-6 signals modulate chromatin binding and promoter occupancy by acetylated FOXP3 PNAS, September 16, 2008; 105(37): 14023 - 14027. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Sander, F. Obermeier, U. Dierssen, D. C. Kroy, A. K. Singh, U. Seidler, K. L. Streetz, H. H. Lutz, W. Muller, F. Tacke, et al. Gp130 Signaling Promotes Development of Acute Experimental Colitis by Facilitating Early Neutrophil/Macrophage Recruitment and Activation J. Immunol., September 1, 2008; 181(5): 3586 - 3594. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. M. Briso, O. Dienz, and M. Rincon Cutting Edge: Soluble IL-6R Is Produced by IL-6R Ectodomain Shedding in Activated CD4 T Cells J. Immunol., June 1, 2008; 180(11): 7102 - 7106. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. G. Zheng, J. Wang, and D. A. Horwitz Cutting Edge: Foxp3+CD4+CD25+ Regulatory T Cells Induced by IL-2 and TGF-{beta} Are Resistant to Th17 Conversion by IL-6 J. Immunol., June 1, 2008; 180(11): 7112 - 7116. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Sarangi, S. Sehrawat, S. Suvas, and B. T. Rouse IL-10 and Natural Regulatory T Cells: Two Independent Anti-Inflammatory Mechanisms in Herpes Simplex Virus-Induced Ocular Immunopathology J. Immunol., May 1, 2008; 180(9): 6297 - 6306. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Rabe, A. Chalaris, U. May, G. H. Waetzig, D. Seegert, A. S. Williams, S. A. Jones, S. Rose-John, and J. Scheller Transgenic blockade of interleukin 6 transsignaling abrogates inflammation Blood, February 1, 2008; 111(3): 1021 - 1028. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |